Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ultrasensitive Detection of Reductions in Cystic Fibrosis Airway Inflammation While Using Aztreonam Lysine for Inhalation Solution

NCT01736839 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.

NCT NCT01736839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01736839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ultrasensitive Detection of Reductions in Cystic Fibrosis Airway Inflammation While Using Aztreonam Lysine for Inhalation Solution
Lead sponsor
National Jewish Health
Phase
Observational
Overall status
Completed
Start date
November 30, 2012
Completion date
July 27, 2017
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis in adults, chronic colonization with pseudomonas aeruginosa